BOTULINUM TOXIN TYPE A

BOTULINUM TOXIN TYPE A was reported 12789 times

BOTULINUM TOXIN TYPE A is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 74 0.4966
1 NEUROMUSCULAR TOXICITY 173 0.4915
2 BOTULISM 285 0.3442
3 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 6 0.2609
4 INFRAPATELLAR FAT PAD INFLAMMATION 5 0.2381
5 NEOVASCULARISATION 59 0.2243
6 FACET JOINT SYNDROME 731 0.2243
7 VASCULAR MALFORMATION 43 0.2048
8 HYPOCHOLESTEROLAEMIA 67 0.1898
9 PARANASAL CYST 43 0.1770
10 BROW PTOSIS 111 0.1692
11 OVERLAP SYNDROME 112 0.1600
12 PERIPHERAL VENOUS DISEASE 626 0.1531
13 BLEPHAROSPASM 895 0.1420
14 MEPHISTO SIGN 10 0.1408
15 ONYCHOMADESIS 522 0.1243
16 BREAST CANCER STAGE III 795 0.1226
17 RHEUMATIC FEVER 539 0.1208
18 SWOLLEN JOINT COUNT 28 0.1120
19 ABERRANT AORTIC ARCH 5 0.1087
20 DUODENAL ULCER PERFORATION 785 0.1055
21 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 713 0.0994
22 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 10 0.0962
23 ONYCHOMYCOSIS 385 0.0877
24 MUSCLE INJURY 653 0.0787
25 INFUSION SITE REACTION 233 0.0779
26 LUPUS VULGARIS 97 0.0770
27 FOLLICULITIS 786 0.0749
28 HELICOBACTER INFECTION 755 0.0734
29 FACIAL ASYMMETRY 70 0.0734
30 FINGER DEFORMITY 349 0.0720
31 NAIL DISORDER 628 0.0717
32 PRIMARY STABBING HEADACHE 5 0.0704
33 POST-TRAUMATIC HEADACHE 11 0.0701
34 LIP DRY 637 0.0701
35 HYPERCHOLESTEROLAEMIA 643 0.0665
36 BURSITIS 795 0.0655
37 LIVE BIRTH 547 0.0653
38 PEMPHIGUS 804 0.0642
39 WOUND INFECTION 698 0.0637
40 DRUG SPECIFIC ANTIBODY 87 0.0635
41 C-REACTIVE PROTEIN 58 0.0626
42 DIAPHRAGMATIC RUPTURE 11 0.0615
43 C-REACTIVE PROTEIN ABNORMAL 388 0.0604
44 X-RAY ABNORMAL 105 0.0587
45 HAND DEFORMITY 770 0.0586
46 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 6 0.0571
47 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 32 0.0570
48 DISLOCATION OF VERTEBRA 128 0.0561
49 PRODUCT LABEL CONFUSION 319 0.0547
50 DERMATOCHALASIS 8 0.0544
51 DEEP VEIN THROMBOSIS POSTOPERATIVE 109 0.0544
52 POST-TRAUMATIC NECK SYNDROME 44 0.0544
53 SOFT TISSUE INJURY 41 0.0542
54 GRIP STRENGTH DECREASED 466 0.0529
55 BACK INJURY 570 0.0524
56 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 100 0.0482
57 EYELID PTOSIS 486 0.0478
58 PERICARDITIS 786 0.0467
59 JOINT RANGE OF MOTION DECREASED 616 0.0459
60 MASTOIDITIS 43 0.0438
61 GRIP STRENGTH 10 0.0437
62 SYNOVITIS 785 0.0435
63 FACIAL DISCOMFORT 30 0.0423
64 COELIAC DISEASE 415 0.0423
65 SWOLLEN JOINT COUNT INCREASED 134 0.0420
66 NEUROPATHIC MUSCULAR ATROPHY 4 0.0408
67 PRODUCT ADMINISTERED BY WRONG PERSON 15 0.0393
68 OBESITY 605 0.0379
69 TASTE DISORDER 765 0.0377
70 PRODUCT PREPARATION ERROR 762 0.0371
71 RETINITIS 64 0.0370
72 VASCULAR GRAFT OCCLUSION 14 0.0365
73 BONE EROSION 126 0.0356
74 PORPHYRIA ACUTE 50 0.0348
75 GLOSSODYNIA 780 0.0348
76 PRODUCT QUALITY CONTROL ISSUE 7 0.0345
77 STERNAL FRACTURE 41 0.0332
78 PRODUCT USED FOR UNKNOWN INDICATION 41 0.0326
79 NEUTRALISING ANTIBODIES 4 0.0317
80 CONGENITAL ANOMALY 245 0.0316
81 IRRITABLE BOWEL SYNDROME 653 0.0304
82 EPILEPSY 918 0.0300
83 RELAPSING MULTIPLE SCLEROSIS 9 0.0298
84 LAGOPHTHALMOS 12 0.0293
85 FIBROMYALGIA 705 0.0290
86 WOUND 715 0.0256
87 SKIN INDENTATION 12 0.0254
88 PRODUCT RECONSTITUTION ISSUE 8 0.0254
89 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 67 0.0252
90 LIVER INJURY 613 0.0249
91 FACIAL PARESIS 88 0.0248
92 ADVERSE REACTION 320 0.0241
93 TYPE 2 DIABETES MELLITUS 795 0.0236
94 SYSTEMIC LUPUS ERYTHEMATOSUS 831 0.0234
95 PRODUCT PREPARATION ISSUE 150 0.0228
96 NORMAL NEWBORN 124 0.0228
97 ENDOMETRIOSIS 106 0.0222
98 LENNOX-GASTAUT SYNDROME 5 0.0220
99 CONTRAINDICATED PRODUCT ADMINISTERED 664 0.0219
100 RHEUMATOID FACTOR POSITIVE 125 0.0216
101 LIVER FUNCTION TEST INCREASED 458 0.0213
102 ATRIOVENTRICULAR SEPTAL DEFECT 10 0.0213
103 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 14 0.0210
104 C-REACTIVE PROTEIN INCREASED 756 0.0208
105 PSORIATIC ARTHROPATHY 827 0.0204
106 LIBIDO INCREASED 41 0.0202
107 IMPAIRED HEALING 658 0.0200
108 MUSCLE HYPERTROPHY 7 0.0199
109 GAIT INABILITY 625 0.0187
110 SALIVARY GLAND PAIN 4 0.0185
111 NEURALGIC AMYOTROPHY 4 0.0177
112 PROCEDURAL ANXIETY 12 0.0177
113 NIGHT SWEATS 562 0.0174
114 PRESCRIBED OVERDOSE 330 0.0170
115 NAIL OPERATION 7 0.0169
116 MYASTHENIC SYNDROME 13 0.0168
117 SEDATION 435 0.0166
118 BREAST CANCER STAGE II 138 0.0166
119 POST VIRAL FATIGUE SYNDROME 4 0.0165
120 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 281 0.0164
121 PARADOXICAL DRUG REACTION 60 0.0163
122 HOSTILITY 41 0.0161
123 PERSONALITY DISORDER 41 0.0156
124 OSTEOARTHRITIS 661 0.0156
125 AUTOIMMUNE DISORDER 151 0.0155
126 BLOOD CHOLESTEROL INCREASED 716 0.0153
127 OTITIS MEDIA 50 0.0151
128 EXOSTOSIS 138 0.0151
129 INFLAMMATION 768 0.0149
130 DRUG-INDUCED LIVER INJURY 465 0.0148
131 ARTHROPATHY 816 0.0147
132 FACIAL PARALYSIS 125 0.0146
133 LOWER RESPIRATORY TRACT INFECTION 658 0.0145
134 DRUG INTOLERANCE 1376 0.0142
135 OCCIPITAL NEURALGIA 8 0.0142
136 HEPATITIS 361 0.0141
137 ACQUIRED DIAPHRAGMATIC EVENTRATION 5 0.0141
138 BLISTER 758 0.0135
139 LID SULCUS DEEPENED 5 0.0134
140 NECK PAIN 749 0.0134
141 SERONEGATIVE ARTHRITIS 15 0.0131
142 ULCER HAEMORRHAGE 86 0.0127
143 MIGRAINE 1211 0.0127
144 NIGHTMARE 435 0.0126
145 LUNG DISORDER 615 0.0125
146 THERAPEUTIC PRODUCT EFFECT DECREASED 546 0.0122
147 RED BLOOD CELL SEDIMENTATION RATE INCREASED 134 0.0121
148 DRUG TOLERANCE 61 0.0120
149 INFUSION RELATED REACTION 788 0.0119
150 DILATED CARDIOMYOPATHY 12 0.0119
151 STOMATITIS 717 0.0118
152 PERIORBITAL PAIN 10 0.0118
153 MATERNAL EXPOSURE TIMING UNSPECIFIED 44 0.0117
154 PERIORBITAL SWELLING 66 0.0117
155 PALATAL DISORDER 7 0.0116
156 WHEEZING 685 0.0115
157 ADMINISTRATION SITE BRUISE 4 0.0115
158 GASTROOESOPHAGEAL REFLUX DISEASE 928 0.0115
159 EYELID FUNCTION DISORDER 9 0.0114
160 FACIAL NERVE DISORDER 5 0.0113
161 MUSCULOSKELETAL PAIN 586 0.0112
162 MATERNAL EXPOSURE DURING PREGNANCY 983 0.0110
163 LIP DISORDER 20 0.0105
164 INJECTION SITE PARAESTHESIA 16 0.0104
165 HEPATIC ENZYME INCREASED 706 0.0103
166 THERAPEUTIC RESPONSE SHORTENED 343 0.0103
167 JOINT DESTRUCTION 16 0.0103
168 MUSCLE SPASTICITY 126 0.0102
169 ABORTION MISSED 13 0.0102
170 DRY MOUTH 812 0.0100
171 SACRAL PAIN 6 0.0099
172 TONGUE PARALYSIS 7 0.0098
173 LUPUS-LIKE SYNDROME 89 0.0098
174 MYCOBACTERIUM ABSCESSUS INFECTION 7 0.0098
175 INJECTION SITE HYPOAESTHESIA 14 0.0098
176 INTENTIONAL PRODUCT USE ISSUE 847 0.0097
177 ACCOMMODATION DISORDER 7 0.0096
178 OTITIS MEDIA ACUTE 7 0.0095
179 VOCAL CORD PARALYSIS 17 0.0095
180 MASTICATION DISORDER 29 0.0095
181 PERIORBITAL CELLULITIS 5 0.0093
182 MUSCULAR WEAKNESS 1055 0.0093
183 SKIN LAXITY 4 0.0091
184 SWELLING 855 0.0091
185 SWOLLEN TONGUE 278 0.0089
186 BLADDER NEOPLASM 15 0.0088
187 PUSTULAR PSORIASIS 30 0.0087
188 EXTRAOCULAR MUSCLE PARESIS 4 0.0087
189 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 56 0.0086
190 DRUG TOLERANCE DECREASED 24 0.0085
191 LACRIMATION DECREASED 4 0.0084
192 MOBILITY DECREASED 603 0.0084
193 SWELLING OF EYELID 52 0.0083
194 OPHTHALMOPLEGIA 13 0.0082
195 AMNESTIC DISORDER 4 0.0082
196 SLEEP DISORDER 578 0.0082
197 EXPOSURE DURING PREGNANCY 505 0.0081
198 SKIN WRINKLING 22 0.0081
199 DIPLOPIA 210 0.0081
200 FACIAL SPASM 9 0.0080
201 NEPHROLITHIASIS 359 0.0078
202 STRABISMUS 23 0.0078
203 HYPOAESTHESIA 1163 0.0078
204 LOWER LIMB FRACTURE 149 0.0077
205 WALKING AID USER 51 0.0077
206 HEAD DISCOMFORT 136 0.0077
207 ASTHENOPIA 42 0.0076
208 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 414 0.0075
209 INFLAMMATORY PAIN 5 0.0074
210 ILL-DEFINED DISORDER 441 0.0073
211 EAR PAIN 141 0.0072
212 EYE INJURY 22 0.0072
213 RHEUMATOID ARTHRITIS 816 0.0072
214 GENERAL PHYSICAL HEALTH DETERIORATION 830 0.0072
215 TREATMENT FAILURE 592 0.0071
216 INJURY 502 0.0071
217 SWELLING FACE 464 0.0071
218 PULMONARY FIBROSIS 135 0.0070
219 DYSPHONIA 404 0.0069
220 ANURIA 59 0.0068
221 HYPOAESTHESIA EYE 4 0.0068
222 DIAPHRAGMATIC PARALYSIS 4 0.0067
223 FACIAL PAIN 59 0.0066
224 ANGIOEDEMA 290 0.0065
225 SUSPECTED PRODUCT QUALITY ISSUE 12 0.0065
226 EYELID DISORDER 15 0.0065
227 INJECTION SITE REACTION 446 0.0065
228 LICHEN PLANUS 15 0.0065
229 PHARYNGEAL HYPOAESTHESIA 6 0.0065
230 INJECTION SITE INDENTATION 14 0.0065
231 INJECTION SITE OEDEMA 11 0.0064
232 SKIN TIGHTNESS 30 0.0064
233 SCIATICA 101 0.0063
234 MUSCULOSKELETAL STIFFNESS 550 0.0063
235 PARAESTHESIA 985 0.0063
236 PRESCRIBED UNDERDOSE 124 0.0062
237 DYSPEPSIA 610 0.0062
238 JOB DISSATISFACTION 4 0.0062
239 TORTICOLLIS 13 0.0061
240 CONCUSSION 47 0.0061
241 JOINT SWELLING 704 0.0058
242 HEAD TITUBATION 8 0.0058
243 DISCOMFORT 353 0.0058
244 PERIORBITAL OEDEMA 30 0.0058
245 EYELID OEDEMA 67 0.0058
246 MEMORY IMPAIRMENT 789 0.0057
247 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 5 0.0057
248 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 407 0.0057
249 OFF LABEL USE 4939 0.0056
250 HEPATIC CIRRHOSIS 105 0.0056
251 RASH VESICULAR 27 0.0056
252 DYSPHAGIA 530 0.0056
253 MIGRAINE WITH AURA 15 0.0055
254 PRODUCT USE IN UNAPPROVED INDICATION 1368 0.0055
255 GASTROINTESTINAL DISORDER 488 0.0054
256 CHANGE OF BOWEL HABIT 11 0.0054
257 CONFUSIONAL STATE 864 0.0053
258 LEFT VENTRICULAR FAILURE 18 0.0052
259 EYE CONTUSION 11 0.0052
260 ALLODYNIA 6 0.0051
261 BRONCHIAL HYPERREACTIVITY 6 0.0050
262 PRODUCT QUALITY ISSUE 670 0.0049
263 REDUCED FACIAL EXPRESSION 5 0.0049
264 FOOD INTOLERANCE 18 0.0049
265 TENSION HEADACHE 21 0.0049
266 SUSPECTED OFF LABEL USE 22 0.0049
267 MUSCLE CONTRACTIONS INVOLUNTARY 17 0.0048
268 PARANASAL SINUS DISCOMFORT 18 0.0048
269 URTICARIA 796 0.0047
270 APPLICATION SITE PAPULES 5 0.0047
271 SPONDYLITIS 17 0.0047
272 DRUG SPECIFIC ANTIBODY PRESENT 30 0.0046
273 MYOSITIS 41 0.0046
274 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 325 0.0046
275 HYPERTENSION 957 0.0045
276 EYE SWELLING 168 0.0045
277 HYPERSENSITIVITY 836 0.0045
278 PRODUCT TEMPERATURE EXCURSION ISSUE 23 0.0045
279 EYELID PAIN 9 0.0044
280 PERIPHERAL SWELLING 681 0.0044
281 ABDOMINAL DISCOMFORT 738 0.0044
282 INCORRECT PRODUCT ADMINISTRATION DURATION 95 0.0044
283 MUSCLE TWITCHING 101 0.0044
284 ABDOMINAL PAIN UPPER 886 0.0043
285 SUSPECTED COUNTERFEIT PRODUCT 17 0.0043
286 SINUS PAIN 10 0.0043
287 MENOPAUSE 11 0.0043
288 NOROVIRUS INFECTION 6 0.0042
289 JOINT STIFFNESS 109 0.0042
290 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 70 0.0041
291 ABDOMINAL DISTENSION 427 0.0041
292 DARK CIRCLES UNDER EYES 6 0.0041
293 MYCOBACTERIAL INFECTION 7 0.0041
294 PARESIS 9 0.0040
295 ASPIRATION 44 0.0040
296 SUPERINFECTION 6 0.0040
297 JOINT DISLOCATION 42 0.0040
298 MUSCLE SPASMS 728 0.0040
299 DEPRESSION 899 0.0039
300 ALOPECIA 770 0.0039
301 BLADDER DYSFUNCTION 4 0.0039
302 IATROGENIC INJURY 5 0.0039
303 RESPIRATORY DISORDER 115 0.0038
304 VIITH NERVE PARALYSIS 13 0.0038
305 GASTROENTERITIS NOROVIRUS 5 0.0038
306 HYPERACUSIS 14 0.0038
307 NEUROMYOPATHY 4 0.0038
308 NODULE 49 0.0038
309 HYPERHIDROSIS 482 0.0037
310 NASOPHARYNGITIS 686 0.0037
311 SLOW SPEECH 9 0.0037
312 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
313 POSTURE ABNORMAL 12 0.0037
314 PHOTOPHOBIA 69 0.0037
315 EFFUSION 5 0.0037
316 MATERNAL EXPOSURE BEFORE PREGNANCY 25 0.0037
317 INFLUENZA LIKE ILLNESS 301 0.0037
318 INJECTION SITE ATROPHY 6 0.0036
319 PATIENT DISSATISFACTION WITH TREATMENT 7 0.0036
320 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
321 DYSLEXIA 4 0.0035
322 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 8 0.0035
323 INTENTIONAL PRODUCT MISUSE 303 0.0035
324 INCISION SITE PAIN 4 0.0034
325 MUSCLE TIGHTNESS 55 0.0034
326 INJECTION SITE NODULE 37 0.0034
327 EYE MOVEMENT DISORDER 23 0.0034
328 VASCULAR OCCLUSION 7 0.0033
329 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 159 0.0033
330 MYOCLONIC EPILEPSY 5 0.0033
331 VITREOUS DETACHMENT 7 0.0032
332 NERVE INJURY 35 0.0031
333 ERYTHEMA OF EYELID 17 0.0031
334 EAR DISCOMFORT 32 0.0031
335 PRODUCT USE ISSUE 573 0.0030
336 VISUAL FIELD DEFECT 22 0.0030
337 NEPHROPATHY TOXIC 34 0.0030
338 DELIRIUM 105 0.0030
339 INJECTION SITE INFLAMMATION 15 0.0030
340 LIP EXFOLIATION 4 0.0030
341 CONDITION AGGRAVATED 909 0.0030
342 CYSTITIS NONINFECTIVE 4 0.0030
343 FUNGAL SKIN INFECTION 12 0.0030
344 WEIGHT INCREASED 665 0.0030
345 UNDERDOSE 216 0.0030
346 SPINAL FUSION SURGERY 12 0.0030
347 VITREOUS FLOATERS 29 0.0029
348 TONGUE DRY 4 0.0029
349 HIP ARTHROPLASTY 45 0.0029
350 HYDROCEPHALUS 16 0.0029
351 THERAPY NON-RESPONDER 131 0.0029
352 HYPOTONIA 29 0.0029
353 ASTHENIA 1090 0.0029
354 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
355 PARALYSIS 41 0.0029
356 ELECTRIC SHOCK SENSATION 8 0.0029
357 HYPOAESTHESIA ORAL 43 0.0028
358 DRUG INEFFECTIVE 3736 0.0028
359 DISABILITY 56 0.0028
360 SKIN HYPOPIGMENTATION 5 0.0028
361 TERMINAL INSOMNIA 5 0.0028
362 GENERAL SYMPTOM 21 0.0028
363 FOOT DEFORMITY 31 0.0028
364 DEREALISATION 6 0.0028
365 OPHTHALMIC HERPES ZOSTER 5 0.0028
366 NASAL OEDEMA 5 0.0028
367 OEDEMA 150 0.0028
368 DYSARTHRIA 104 0.0028
369 VISION BLURRED 377 0.0027
370 STRIDOR 8 0.0027
371 TRISMUS 14 0.0027
372 INJECTION SITE MASS 100 0.0027
373 DRUG EFFECT DECREASED 145 0.0027
374 CONTUSION 259 0.0027
375 TENDERNESS 28 0.0027
376 AURA 5 0.0027
377 BLADDER SPASM 5 0.0027
378 CHOKING 52 0.0027
379 SACROILIITIS 5 0.0026
380 PREGNANCY 53 0.0026
381 HEADACHE 1657 0.0026
382 THERAPEUTIC RESPONSE DECREASED 159 0.0026
383 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
384 GENITAL HERPES 4 0.0026
385 GRANULOMA 9 0.0026
386 BODY TEMPERATURE INCREASED 53 0.0026
387 OVERDOSE 559 0.0026
388 AORTIC STENOSIS 9 0.0026
389 CHOKING SENSATION 14 0.0025
390 MONOPLEGIA 11 0.0025
391 PHOTOPSIA 16 0.0025
392 INAPPROPRIATE AFFECT 4 0.0025
393 ADVERSE EVENT 232 0.0025
394 ROAD TRAFFIC ACCIDENT 105 0.0025
395 POOR QUALITY SLEEP 54 0.0025
396 INJECTION SITE SWELLING 192 0.0025
397 BRAIN INJURY 25 0.0025
398 INJECTION SITE DISCOMFORT 26 0.0025
399 POLYARTHRITIS 13 0.0025
400 BREAST DISORDER 5 0.0024
401 EYE OEDEMA 6 0.0024
402 ASTHMA 276 0.0024
403 FOETAL EXPOSURE DURING PREGNANCY 198 0.0024
404 SPEECH DISORDER 127 0.0024
405 FINE MOTOR SKILL DYSFUNCTION 7 0.0024
406 EXTRAPYRAMIDAL DISORDER 60 0.0024
407 QUADRIPARESIS 4 0.0024
408 MIDDLE INSOMNIA 45 0.0024
409 FREQUENT BOWEL MOVEMENTS 65 0.0024
410 EYELID IRRITATION 6 0.0024
411 DIZZINESS 1182 0.0024
412 MYASTHENIA GRAVIS 19 0.0024
413 CERVICAL SPINAL STENOSIS 4 0.0023
414 DROOLING 16 0.0023
415 FACIAL PALSY 5 0.0023
416 FEELING HOT 139 0.0023
417 RETROPERITONEAL HAEMATOMA 5 0.0023
418 EYELIDS PRURITUS 7 0.0022
419 BLEPHARITIS 9 0.0022
420 MUSCLE DISORDER 18 0.0022
421 EAR CONGESTION 6 0.0022
422 MONOPARESIS 4 0.0022
423 INCORRECT ROUTE OF DRUG ADMINISTRATION 79 0.0022
424 MUSCLE ATROPHY 28 0.0022
425 JAW DISORDER 12 0.0022
426 RHINALGIA 6 0.0022
427 OESOPHAGEAL SPASM 4 0.0022
428 LYMPH NODE PAIN 4 0.0021
429 INJECTION SITE INFECTION 7 0.0021
430 INSOMNIA 565 0.0021
431 PUSTULE 5 0.0021
432 LIP PAIN 6 0.0021
433 EYELID MARGIN CRUSTING 6 0.0021
434 PNEUMONIA 665 0.0021
435 DRY EYE 102 0.0020
436 RIB FRACTURE 42 0.0020
437 JOINT NOISE 4 0.0020
438 IMMUNODEFICIENCY 30 0.0020
439 ARTHRALGIA 835 0.0020
440 LIVER DISORDER 89 0.0020
441 EAR INFECTION 53 0.0020
442 OSTEOPOROSIS 80 0.0019
443 RASH 846 0.0019
444 SPINAL STENOSIS 8 0.0019
445 IMPAIRED DRIVING ABILITY 22 0.0019
446 NEURALGIA 47 0.0019
447 THROAT TIGHTNESS 52 0.0019
448 PAIN 1178 0.0019
449 WALKING DISABILITY 4 0.0019
450 VOMITING 898 0.0019
451 VERTIGO 116 0.0019
452 KNEE ARTHROPLASTY 40 0.0019
453 PRODUCT PACKAGING ISSUE 18 0.0019
454 BLADDER PAIN 6 0.0019
455 EAR SWELLING 4 0.0019
456 OCULAR DISCOMFORT 21 0.0019
457 HYPERTRANSAMINASAEMIA 13 0.0019
458 OCULOGYRIC CRISIS 4 0.0019
459 APHONIA 26 0.0019
460 EXOPHTHALMOS 4 0.0019
461 LARYNGOSPASM 5 0.0019
462 CHONDROPATHY 5 0.0018
463 PAIN IN EXTREMITY 540 0.0018
464 AMNESIA 119 0.0018
465 DEAFNESS NEUROSENSORY 6 0.0018
466 SEROTONIN SYNDROME 35 0.0018
467 SUSPECTED COVID-19 6 0.0018
468 THERAPY PARTIAL RESPONDER 28 0.0018
469 OROPHARYNGEAL DISCOMFORT 16 0.0018
470 PETIT MAL EPILEPSY 9 0.0018
471 PANIC ATTACK 64 0.0018
472 INJECTION SITE PAPULE 8 0.0017
473 HYPERTONIC BLADDER 5 0.0017
474 SINUSITIS 177 0.0017
475 WEIGHT FLUCTUATION 18 0.0017
476 ARTHRITIS 135 0.0017
477 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
478 PAPULE 12 0.0017
479 CONGESTIVE CARDIOMYOPATHY 7 0.0017
480 NAUSEA 1328 0.0017
481 SENSATION OF FOREIGN BODY 14 0.0017
482 HYPERCAPNIA 5 0.0017
483 MUSCLE FATIGUE 7 0.0017
484 URINARY RETENTION 55 0.0016
485 SKIN MASS 11 0.0016
486 ADVERSE DRUG REACTION 147 0.0016
487 TINNITUS 75 0.0016
488 BLINDNESS TRANSIENT 12 0.0016
489 UPPER RESPIRATORY TRACT INFECTION 75 0.0016
490 DYSPNOEA 916 0.0016
491 SUFFOCATION FEELING 4 0.0016
492 INJECTION SITE ABSCESS 4 0.0016
493 APHASIA 48 0.0016
494 LACRIMATION INCREASED 48 0.0016
495 WRONG TECHNIQUE IN DRUG USAGE PROCESS 57 0.0016
496 IMPAIRED WORK ABILITY 33 0.0015
497 CATHETER SITE PAIN 4 0.0015
498 FACE OEDEMA 26 0.0015
499 BACK DISORDER 25 0.0015
500 MEDICATION ERROR 85 0.0015
501 PNEUMONIA ASPIRATION 38 0.0015
502 INCONTINENCE 16 0.0015
503 NASAL DISCOMFORT 12 0.0015
504 EXPOSURE VIA BREAST MILK 6 0.0015
505 MAJOR DEPRESSION 11 0.0015
506 AREFLEXIA 4 0.0015
507 MALAISE 657 0.0015
508 TEMPOROMANDIBULAR JOINT SYNDROME 4 0.0015
509 DECREASED APPETITE 347 0.0015
510 PRODUCT STORAGE ERROR 130 0.0015
511 DISTURBANCE IN ATTENTION 80 0.0015
512 TYPE IV HYPERSENSITIVITY REACTION 4 0.0015
513 EYE DISORDER 48 0.0015
514 PAROSMIA 11 0.0015
515 DEAFNESS UNILATERAL 8 0.0015
516 HEMIPLEGIA 12 0.0014
517 INJECTION SITE DISCOLOURATION 18 0.0014
518 INTRACRANIAL PRESSURE INCREASED 8 0.0014
519 FATIGUE 1115 0.0014
520 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
521 URINARY INCONTINENCE 42 0.0014
522 UROSEPSIS 13 0.0014
523 INJECTION SITE SCAR 4 0.0014
524 VISUAL IMPAIRMENT 173 0.0014
525 ABNORMAL SENSATION IN EYE 6 0.0014
526 FALL 464 0.0014
527 PHOTOSENSITIVITY REACTION 23 0.0014
528 PHARYNGEAL DISORDER 4 0.0014
529 PANIC REACTION 10 0.0014
530 LIP SWELLING 46 0.0014
531 MOTOR DYSFUNCTION 14 0.0014
532 RASH PUSTULAR 10 0.0014
533 CHRONIC KIDNEY DISEASE 104 0.0014
534 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
535 MASS 19 0.0014
536 PHYSICAL DISABILITY 6 0.0014
537 DENTAL CARIES 15 0.0014
538 SCAR 23 0.0013
539 HYPERAESTHESIA 11 0.0013
540 ABDOMINAL PAIN 311 0.0013
541 EYE INFECTION 15 0.0013
542 ACNE CYSTIC 4 0.0013
543 ADRENAL INSUFFICIENCY 16 0.0013
544 KERATITIS 4 0.0013
545 TROPONIN INCREASED 10 0.0013
546 INJECTION SITE PAIN 402 0.0013
547 ANXIETY 368 0.0013
548 VITAMIN D DECREASED 11 0.0013
549 EPIGASTRIC DISCOMFORT 5 0.0013
550 INJECTION SITE HYPERSENSITIVITY 4 0.0013
551 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
552 EYE PAIN 72 0.0013
553 BRAIN FOG 20 0.0013
554 DRUG EFFECT INCREASED 4 0.0013
555 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
556 MULTIPLE USE OF SINGLE-USE PRODUCT 7 0.0012
557 HEMIPARESIS 21 0.0012
558 DIARRHOEA 793 0.0012
559 LABORATORY TEST ABNORMAL 36 0.0012
560 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
561 INCORRECT PRODUCT STORAGE 16 0.0012
562 CEREBRAL DISORDER 9 0.0012
563 HERPES VIRUS INFECTION 7 0.0012
564 ANEURYSM 6 0.0012
565 SALIVARY HYPERSECRETION 12 0.0012
566 PSORIASIS 155 0.0012
567 DYSTONIA 23 0.0012
568 GAIT DISTURBANCE 226 0.0012
569 DRY THROAT 12 0.0012
570 TEARFULNESS 5 0.0012
571 MYOPATHY 10 0.0012
572 INJECTION SITE VESICLES 7 0.0012
573 HORDEOLUM 5 0.0012
574 EYE DISCHARGE 12 0.0012
575 HYPERREFLEXIA 4 0.0011
576 DYSPHEMIA 5 0.0011
577 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
578 INFECTION 164 0.0011
579 GINGIVAL SWELLING 5 0.0011
580 WEIGHT DECREASED 316 0.0011
581 SENSORY DISTURBANCE 18 0.0011
582 GINGIVITIS 6 0.0011
583 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
584 PHARYNGITIS STREPTOCOCCAL 12 0.0011
585 CHEST PAIN 205 0.0011
586 SCLERODERMA 4 0.0011
587 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
588 MYDRIASIS 14 0.0011
589 EYE PRURITUS 36 0.0011
590 RECTAL HAEMORRHAGE 46 0.0011
591 INJECTION SITE URTICARIA 26 0.0011
592 PERONEAL NERVE PALSY 6 0.0011
593 BURNING SENSATION 74 0.0011
594 FACE INJURY 4 0.0011
595 PRE-ECLAMPSIA 5 0.0011
596 HYPERTONIA 6 0.0010
597 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
598 MUSCULOSKELETAL DISCOMFORT 18 0.0010
599 LIMB DISCOMFORT 32 0.0010
600 PANIC DISORDER 4 0.0010
601 INJECTION SITE ERYTHEMA 128 0.0010
602 SENSATION OF HEAVINESS 4 0.0010
603 TREMOR 171 0.0010
604 LYMPHADENOPATHY 36 0.0010
605 ENCEPHALITIS 7 0.0010
606 INJECTION SITE INDURATION 13 0.0010
607 PANCREATITIS 53 0.0010
608 SYMPTOM RECURRENCE 6 0.0010
609 TRIGEMINAL NEURALGIA 4 0.0010
610 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
611 TENSION 6 0.0010
612 RASH PAPULAR 22 0.0010
613 ELECTROCARDIOGRAM QT PROLONGED 35 0.0010
614 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 196 0.0010
615 MENTAL DISORDER 42 0.0010
616 DEFORMITY 9 0.0010
617 POISONING 12 0.0010
618 TONGUE DISCOMFORT 4 0.0009
619 NYSTAGMUS 5 0.0009
620 FEEDING DISORDER 19 0.0009
621 SKIN DISCOLOURATION 43 0.0009
622 CHEST DISCOMFORT 95 0.0009
623 BRUXISM 5 0.0009
624 SKIN REACTION 13 0.0009
625 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
626 THYROID DISORDER 14 0.0009
627 BLADDER DISORDER 9 0.0009
628 OCULAR HYPERAEMIA 43 0.0009
629 MOVEMENT DISORDER 29 0.0009
630 PALPITATIONS 105 0.0009
631 ANAL INCONTINENCE 8 0.0009
632 IMPAIRED GASTRIC EMPTYING 12 0.0009
633 NEUROLOGICAL SYMPTOM 5 0.0009
634 EAR DISORDER 4 0.0009
635 VENTRICULAR SEPTAL DEFECT 5 0.0009
636 SENSORY LOSS 7 0.0009
637 INJECTION SITE BRUISING 69 0.0009
638 INJECTION SITE IRRITATION 11 0.0009
639 OROPHARYNGEAL PAIN 80 0.0009
640 FORMICATION 6 0.0009
641 DYSGEUSIA 64 0.0009
642 PYREXIA 298 0.0009
643 SINUS DISORDER 17 0.0009
644 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
645 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
646 IRRITABILITY 51 0.0008
647 CYSTITIS 27 0.0008
648 HAND FRACTURE 6 0.0008
649 MENSTRUAL DISORDER 7 0.0008
650 SINUS HEADACHE 5 0.0008
651 BEDRIDDEN 11 0.0008
652 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
653 RESPIRATORY DISTRESS 23 0.0008
654 TACHYCARDIA 74 0.0008
655 OEDEMA PERIPHERAL 101 0.0008
656 SKIN LACERATION 9 0.0008
657 INJECTION SITE HAEMATOMA 12 0.0008
658 GUILLAIN-BARRE SYNDROME 4 0.0008
659 BRONCHITIS 61 0.0008
660 MENISCUS INJURY 5 0.0008
661 PYELONEPHRITIS 7 0.0008
662 FEELING DRUNK 6 0.0008
663 SKIN SWELLING 7 0.0008
664 ANGINA PECTORIS 23 0.0008
665 VEIN DISORDER 4 0.0008
666 SEIZURE 92 0.0008
667 MYALGIA 134 0.0008
668 PRESYNCOPE 19 0.0008
669 VIRAL INFECTION 26 0.0008
670 PAIN IN JAW 22 0.0008
671 MADAROSIS 9 0.0008
672 TENDON DISORDER 5 0.0008
673 INJECTION SITE PRURITUS 51 0.0008
674 DYSGRAPHIA 5 0.0008
675 ATAXIA 9 0.0008
676 HYPOKINESIA 11 0.0008
677 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
678 FRUSTRATION TOLERANCE DECREASED 6 0.0007
679 DRUG RESISTANCE 19 0.0007
680 FEELING ABNORMAL 175 0.0007
681 PERIPHERAL COLDNESS 10 0.0007
682 AUTISM SPECTRUM DISORDER 4 0.0007
683 RESPIRATION ABNORMAL 5 0.0007
684 EATING DISORDER 15 0.0007
685 PALLOR 19 0.0007
686 IMPAIRED QUALITY OF LIFE 10 0.0007
687 MOUTH SWELLING 4 0.0007
688 PRODUCT ADMINISTRATION ERROR 14 0.0007
689 TONGUE DISORDER 5 0.0007
690 HYPERVENTILATION 4 0.0007
691 ORAL DISORDER 5 0.0007
692 INJECTION SITE WARMTH 14 0.0007
693 HYPOTENSION 136 0.0007
694 SENSITIVE SKIN 5 0.0007
695 BRADYKINESIA 4 0.0007
696 MYOCLONUS 8 0.0007
697 FEAR 18 0.0007
698 COGNITIVE DISORDER 31 0.0007
699 TOOTHACHE 12 0.0007
700 EYE IRRITATION 38 0.0007
701 FOETAL GROWTH RESTRICTION 4 0.0007
702 BRAIN NEOPLASM 6 0.0007
703 DYSSTASIA 19 0.0007
704 FLUSHING 66 0.0006
705 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
706 ORAL DISCOMFORT 9 0.0006
707 SCOLIOSIS 4 0.0006
708 PHARYNGITIS 8 0.0006
709 CYST 8 0.0006
710 HOSPITALISATION 99 0.0006
711 BACTERIAL INFECTION 12 0.0006
712 OXYGEN SATURATION DECREASED 36 0.0006
713 NASAL DRYNESS 4 0.0006
714 DERMATITIS ALLERGIC 8 0.0006
715 GINGIVAL PAIN 5 0.0006
716 ERYTHEMA 129 0.0006
717 FOREIGN BODY SENSATION IN EYES 4 0.0006
718 HEART RATE INCREASED 62 0.0006
719 BLOOD PRESSURE FLUCTUATION 15 0.0006
720 PRURITUS 239 0.0006
721 POOR QUALITY DRUG ADMINISTERED 4 0.0006
722 RASH GENERALISED 16 0.0006
723 ANAPHYLACTIC REACTION 34 0.0006
724 DYSKINESIA 25 0.0006
725 DERMATITIS CONTACT 7 0.0006
726 SCAB 7 0.0006
727 PHARYNGEAL SWELLING 6 0.0006
728 MICTURITION URGENCY 7 0.0006
729 ASPHYXIA 5 0.0006
730 LOSS OF CONSCIOUSNESS 78 0.0006
731 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
732 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
733 EMBOLISM 5 0.0006
734 SYNCOPE 60 0.0006
735 BACK PAIN 138 0.0006
736 SINUS CONGESTION 8 0.0006
737 WRONG PRODUCT ADMINISTERED 4 0.0006
738 INJECTION SITE RASH 18 0.0006
739 COLITIS ULCERATIVE 26 0.0006
740 LYMPHOEDEMA 4 0.0006
741 MUSCLE STRAIN 5 0.0006
742 MUSCULOSKELETAL DISORDER 11 0.0006
743 HEART RATE IRREGULAR 13 0.0006
744 LETHARGY 33 0.0006
745 LOCAL SWELLING 10 0.0006
746 EXTRASYSTOLES 4 0.0006
747 DYSURIA 21 0.0006
748 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
749 BREAST PAIN 6 0.0006
750 DYSPNOEA EXERTIONAL 21 0.0006
751 PARAESTHESIA ORAL 8 0.0006
752 CRYING 20 0.0005
753 DEPRESSED MOOD 29 0.0005
754 CHILLS 64 0.0005
755 RHINORRHOEA 35 0.0005
756 VENTRICULAR FIBRILLATION 6 0.0005
757 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
758 ARTHROPOD BITE 4 0.0005
759 SKIN DISORDER 18 0.0005
760 HERPES ZOSTER 31 0.0005
761 RESPIRATORY TRACT INFECTION 14 0.0005
762 THROAT IRRITATION 24 0.0005
763 URINARY TRACT INFECTION 91 0.0005
764 PEMPHIGOID 4 0.0005
765 NASAL CONGESTION 31 0.0005
766 SOMNOLENCE 105 0.0005
767 ACCIDENTAL OVERDOSE 19 0.0005
768 BLINDNESS 21 0.0005
769 GINGIVAL BLEEDING 7 0.0005
770 VISUAL ACUITY REDUCED 17 0.0005
771 FLUID RETENTION 26 0.0005
772 BODY TEMPERATURE DECREASED 5 0.0005
773 MUSCLE RIGIDITY 6 0.0005
774 MIOSIS 4 0.0005
775 BLINDNESS UNILATERAL 7 0.0005
776 MENTAL IMPAIRMENT 12 0.0005
777 RESPIRATORY FAILURE 36 0.0005
778 DECUBITUS ULCER 4 0.0005
779 COUGH 137 0.0005
780 EXPIRED PRODUCT ADMINISTERED 16 0.0005
781 RASH PRURITIC 26 0.0005
782 SECRETION DISCHARGE 6 0.0005
783 DERMATITIS 10 0.0005
784 SKIN LESION 13 0.0005
785 RENAL PAIN 5 0.0005
786 HEPATIC CYTOLYSIS 6 0.0005
787 HYPOPHAGIA 12 0.0005
788 POST PROCEDURAL COMPLICATION 9 0.0005
789 RASH ERYTHEMATOUS 22 0.0005
790 BIPOLAR DISORDER 5 0.0005
791 DEAFNESS 12 0.0005
792 BLOOD CALCIUM INCREASED 4 0.0005
793 COLD SWEAT 8 0.0005
794 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
795 EYE HAEMORRHAGE 6 0.0004
796 NERVOUS SYSTEM DISORDER 14 0.0004
797 THIRST 8 0.0004
798 DRUG INTERACTION 71 0.0004
799 SNEEZING 10 0.0004
800 CYANOSIS 7 0.0004
801 HEAVY MENSTRUAL BLEEDING 4 0.0004
802 GASTROENTERITIS VIRAL 8 0.0004
803 PNEUMOTHORAX 7 0.0004
804 BALANCE DISORDER 38 0.0004
805 TREATMENT NONCOMPLIANCE 24 0.0004
806 GASTRIC DISORDER 15 0.0004
807 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8 0.0004
808 RESPIRATORY ARREST 12 0.0004
809 RETINAL DETACHMENT 4 0.0004
810 HYPOKALAEMIA 20 0.0004
811 PROCEDURAL PAIN 12 0.0004
812 THINKING ABNORMAL 8 0.0004
813 APPENDICITIS 4 0.0004
814 UNEVALUABLE EVENT 32 0.0004
815 EYE INFLAMMATION 4 0.0004
816 POLYNEUROPATHY 5 0.0004
817 ANOSMIA 6 0.0004
818 HYPERTHYROIDISM 6 0.0004
819 INJECTION SITE HAEMORRHAGE 33 0.0004
820 INFLAMMATORY BOWEL DISEASE 4 0.0004
821 KNEE OPERATION 4 0.0004
822 INJECTION SITE EXTRAVASATION 5 0.0004
823 LIGAMENT SPRAIN 4 0.0004
824 GENERALISED OEDEMA 5 0.0004
825 ORTHOSTATIC HYPOTENSION 7 0.0004
826 NERVOUSNESS 21 0.0004
827 HEART RATE DECREASED 14 0.0004
828 CELLULITIS 20 0.0004
829 BRADYCARDIA 21 0.0004
830 PHARYNGEAL OEDEMA 6 0.0004
831 TEMPERATURE INTOLERANCE 4 0.0004
832 POOR VENOUS ACCESS 4 0.0004
833 HAEMATOMA 10 0.0004
834 CEREBROVASCULAR ACCIDENT 65 0.0004
835 PETECHIAE 4 0.0004
836 ORAL CANDIDIASIS 5 0.0004
837 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
838 ABORTION SPONTANEOUS 15 0.0004
839 QUALITY OF LIFE DECREASED 5 0.0004
840 PRURITUS GENERALISED 8 0.0004
841 CONVULSION 21 0.0004
842 MOOD ALTERED 10 0.0004
843 ABASIA 9 0.0004
844 COORDINATION ABNORMAL 5 0.0004
845 KIDNEY INFECTION 7 0.0004
846 SKIN INFECTION 4 0.0004
847 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
848 INFLUENZA 39 0.0003
849 VASCULITIS 4 0.0003
850 APATHY 5 0.0003
851 NO ADVERSE EVENT 62 0.0003
852 BONE PAIN 20 0.0003
853 SEXUAL DYSFUNCTION 4 0.0003
854 LEUKOPENIA 17 0.0003
855 TOXICITY TO VARIOUS AGENTS 57 0.0003
856 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
857 MULTIPLE SCLEROSIS 16 0.0003
858 PAIN OF SKIN 9 0.0003
859 DISORIENTATION 13 0.0003
860 SUICIDAL IDEATION 30 0.0003
861 CONJUNCTIVITIS 6 0.0003
862 PRODUCT PRESCRIBING ISSUE 7 0.0003
863 MENINGIOMA 5 0.0003
864 BRAIN OEDEMA 4 0.0003
865 RASH MACULAR 11 0.0003
866 ACUTE RESPIRATORY FAILURE 6 0.0003
867 ROTATOR CUFF SYNDROME 4 0.0003
868 ACUTE MYOCARDIAL INFARCTION 9 0.0003
869 GASTRITIS 8 0.0003
870 DRUG EFFECT INCOMPLETE 11 0.0003
871 HYPOACUSIS 13 0.0003
872 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
873 DRUG TOXICITY 4 0.0003
874 CIRCULATORY COLLAPSE 5 0.0003
875 PRODUCTIVE COUGH 14 0.0003
876 HAEMATURIA 10 0.0003
877 ILLNESS 30 0.0003
878 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
879 PERITONITIS 6 0.0003
880 BLOOD PRESSURE INCREASED 44 0.0003
881 COVID-19 50 0.0003
882 MOUTH ULCERATION 6 0.0003
883 HEAD INJURY 9 0.0003
884 LYMPHOCYTE COUNT DECREASED 5 0.0003
885 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
886 HIP FRACTURE 9 0.0003
887 CEREBRAL HAEMORRHAGE 10 0.0003
888 GASTROENTERITIS 4 0.0003
889 APPLICATION SITE PAIN 6 0.0003
890 ANAPHYLACTIC SHOCK 7 0.0003
891 BLOOD PRESSURE DECREASED 18 0.0003
892 ORAL PAIN 6 0.0003
893 CARDIAC DISORDER 25 0.0003
894 ACNE 20 0.0003
895 SLEEP APNOEA SYNDROME 5 0.0003
896 ORAL HERPES 5 0.0003
897 SEPTIC SHOCK 11 0.0003
898 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
899 DEATH 213 0.0002
900 RESTLESSNESS 9 0.0002
901 STAPHYLOCOCCAL INFECTION 8 0.0002
902 AGEUSIA 6 0.0002
903 CONSTIPATION 52 0.0002
904 PRODUCT COMPLAINT 6 0.0002
905 DEHYDRATION 31 0.0002
906 EMOTIONAL DISTRESS 28 0.0002
907 ECZEMA 12 0.0002
908 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
909 HYPOXIA 8 0.0002
910 EMOTIONAL DISORDER 7 0.0002
911 STEVENS-JOHNSON SYNDROME 5 0.0002
912 PELVIC PAIN 4 0.0002
913 CARDIO-RESPIRATORY ARREST 9 0.0002
914 FOOT FRACTURE 4 0.0002
915 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
916 FEELING JITTERY 4 0.0002
917 HYPOGLYCAEMIA 10 0.0002
918 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
919 ABDOMINAL PAIN LOWER 5 0.0002
920 SKIN IRRITATION 9 0.0002
921 RHABDOMYOLYSIS 8 0.0002
922 POLLAKIURIA 8 0.0002
923 ARRHYTHMIA 9 0.0002
924 SKIN EXFOLIATION 16 0.0002
925 COMA 9 0.0002
926 MOOD SWINGS 6 0.0002
927 SURGERY 11 0.0002
928 RETCHING 4 0.0002
929 SKIN CANCER 4 0.0002
930 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
931 CHOLELITHIASIS 6 0.0002
932 FEELING COLD 5 0.0002
933 CHROMATURIA 4 0.0002
934 ABNORMAL BEHAVIOUR 7 0.0002
935 SHOCK 4 0.0002
936 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
937 DIABETES MELLITUS 13 0.0002
938 BLOOD POTASSIUM DECREASED 5 0.0002
939 NEOPLASM MALIGNANT 11 0.0002
940 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
941 INTESTINAL OBSTRUCTION 6 0.0002
942 HAEMATEMESIS 4 0.0002
943 NEUROPATHY PERIPHERAL 15 0.0002
944 HYPOTHYROIDISM 5 0.0002
945 DRUG ABUSE 13 0.0002
946 HAEMOGLOBIN DECREASED 16 0.0002
947 ERECTILE DYSFUNCTION 4 0.0002
948 DEEP VEIN THROMBOSIS 10 0.0002
949 PLEURAL EFFUSION 9 0.0001
950 HOT FLUSH 11 0.0001
951 DRY SKIN 19 0.0001
952 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
953 NEEDLE ISSUE 4 0.0001
954 PULMONARY EMBOLISM 13 0.0001
955 AGITATION 10 0.0001
956 CATARACT 8 0.0001
957 MYOCARDIAL INFARCTION 23 0.0001
958 DRUG ADMINISTRATION ERROR 4 0.0001
959 HAEMATOCHEZIA 7 0.0001
960 METABOLIC ACIDOSIS 4 0.0001
961 CARDIAC ARREST 10 0.0001
962 ANGER 4 0.0001
963 NEOPLASM PROGRESSION 4 0.0001
964 DRUG DEPENDENCE 18 0.0001
965 EPISTAXIS 8 0.0001
966 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
967 HALLUCINATION 8 0.0001
968 HAEMORRHAGE 11 0.0001
969 CARDIAC FAILURE 8 0.0001
970 ANAEMIA 19 0.0001
971 THROMBOSIS 8 0.0001
972 SEPSIS 11 0.0001
973 SKIN BURNING SENSATION 7 0.0001
974 THERAPY CESSATION 5 0.0001
975 DISEASE PROGRESSION 11 0.0001
976 INCORRECT DOSE ADMINISTERED 21 0.0001
977 HYPONATRAEMIA 5 0.0001
978 FLATULENCE 5 0.0001
979 BREAST CANCER 8 0.0001
980 PLATELET COUNT DECREASED 9 0.0001
981 DISEASE RECURRENCE 4 0.0001
982 BLOOD GLUCOSE DECREASED 4 0.0001
983 AGGRESSION 4 0.0001
984 ATRIAL FIBRILLATION 7 0.0001
985 THROMBOCYTOPENIA 8 0.0001
986 PRODUCT DOSE OMISSION ISSUE 21 0.0001
987 PRODUCT DOSE OMISSION 4 0.0001
988 THERAPY INTERRUPTED 4 0.0001
989 DEVICE ISSUE 5 0.0001
990 ACUTE KIDNEY INJURY 8 0.0001
991 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
992 RENAL IMPAIRMENT 4 0.0000
993 BLOOD GLUCOSE INCREASED 7 0.0000
994 RENAL FAILURE 4 0.0000